Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
2.47
0.20 (8.81%)
At close: Jun 16, 2025, 3:59 PM
2.48
0.40%
Pre-market: Jun 17, 2025, 08:24 AM EDT
8.81% (1D)
| Bid | 2.24 |
| Market Cap | 11.85M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.76M |
| EPS (ttm) | -9.02 |
| PE Ratio (ttm) | -0.27 |
| Forward PE | -2.72 |
| Analyst | Buy |
| Ask | 2.55 |
| Volume | 142,217 |
| Avg. Volume (20D) | 3,271,022 |
| Open | 2.27 |
| Previous Close | 2.27 |
| Day's Range | 2.27 - 2.50 |
| 52-Week Range | 0.97 - 9.79 |
| Beta | 0.85 |
About PHIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+17.14%
Phio Pharmaceuticals shares are trading higher HC ...
Unlock content with
Pro Subscription
1 month ago
+18.6%
Phio Pharmaceuticals shares are trading higher after the company announced pathology results from the third cohort in its INTASYL PH-762 skin cancer clinical trial.
